XClose

UCL Institute of Neurology

Home
Menu

UCL Institute of Neurology

Research and teaching excellence

The Institute of Neurology has a world class reputation for neuroscience. The mission is to translate neuroscience discovery research into treatments for patients with neurological diseases.  A number of important research centres are based at the Institute, including the MRC Centre for Neuromuscular Diseases and the Wellcome Centre for Human Neuroimaging

The hub of the research activities and operational headquarters of the UK Dementia Research Institute (DRI) are also at UCL, embedded within the Institute.

Professor Michael Hanna is the Director of the Institute, which is a specialist postgraduate institute of University College London, the top-ranked university in the UK for research in Psychology, Psychiatry and Neuroscience. 

The Institute is closely associated in its work with the National Hospital for Neurology & Neurosurgery. In combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.

What We Do

Please see our Infographic highlighting key data on the Institute.

Discovery research

The overarching research mission of the Institute is to undertake world class discovery neuroscience and translate it into improved diagnostics and treatments for patients.

Translational science

The Institute aims to be the translational experimental medicine hub of UCL Neuroscience, translating pre-clinical science into experimental medicine research

Study

Queen Square is an international leader in the provision of research-led education in clinical neuroscience and has a leadership role in clinical training nationally.

IoN News

Queen Square Inaugural Lectures

UCL Institute of Neurology is pleased to report on its sixth set of inaugural lectures held on 12th December 2017.

Published: Dec 13, 2017 9:29:00 AM

Drug lowers deadly Huntington’s disease protein

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial, and successfully lowered the level of the harmful huntingtin protein in the nervous system.

Published: Dec 11, 2017 12:51:02 PM

Uncertainty and inference

New research by Thomas Parr and Karl Friston, UCL Institute of Neurology, draws upon recent advances in theoretical neurobiology to try to understand how the brain might solve the problem of dealing with environmental uncertainty.

Published: Nov 30, 2017 9:12:28 AM